Drug Shortage Report for SURVANTA
| Report ID | 226027 |
| Drug Identification Number | 02016109 |
| Brand name | SURVANTA |
| Common or Proper name | Survanta |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | BERACTANT |
| Strength(s) | 25MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRATRACHEAL INTRATRACHEAL |
| Packaging size | 4mL and 8 mL |
| ATC code | R07AA |
| ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-29 |
| Estimated end date | 2024-05-14 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2024-05-01 | French | Compare |
| v11 | 2024-05-01 | English | Compare |
| v10 | 2024-04-30 | English | Compare |
| v9 | 2024-04-29 | French | Compare |
| v8 | 2024-04-29 | English | Compare |
| v7 | 2024-04-26 | French | Compare |
| v6 | 2024-04-26 | English | Compare |
| v5 | 2024-04-24 | English | Compare |
| v4 | 2024-04-24 | French | Compare |
| v3 | 2024-04-24 | English | Compare |
| v2 | 2024-04-24 | French | Compare |
| v1 | 2024-04-24 | English | Compare |
Showing 1 to 12 of 12